“Our goal is to translate advances in computation and artificial intelligence into better medicines for patients,” said Zhangming Niu, Founder and Chief Executive Officer of MindRank. “By integrating biological, chemical, computational and clinical data into a continuously learning R&D engine, MAP is designed to make drug discovery and development more predictable, scalable and capital-efficient.”
